Conservation of whole body nitric oxide metabolism in human alcoholic liver disease: Implications for nitric oxide production

Scandinavian Journal of Gastroenterology

Volumn 41, Issue 7, 2006, Pages 820-825

  Demoncheaux, Eric ^a   Elphick, David ^b   Dürner, Marc ^b   Higgins, Gail ^b   Crowther, David ^b   Williams, Earl ^b   Higenbottam, Tim ^b   Gleeson, Dermot ^b  

^a UNIV LILLE   (France)

^b NONE

Author keywords

Cirrhosis; Liver; Nitric oxide; Portal hypertension

Indexed keywords

ARGININE; CREATININE; NITRATE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITE; NITROGEN 15;

ADULT; ALCOHOL LIVER DISEASE; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ENZYME ACTIVITY; FEMALE; HUMAN; ION PAIR CHROMATOGRAPHY; LIVER FAILURE; MALE; MASS SPECTROMETRY; METABOLISM; PATHOGENESIS; PORTAL HYPERTENSION; PRIORITY JOURNAL; URINE LEVEL;

ARGININE; CASE-CONTROL STUDIES; FEMALE; HUMANS; HYPERTENSION, PORTAL; LIVER; LIVER CIRRHOSIS, ALCOHOLIC; MALE; MIDDLE AGED; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROGEN ISOTOPES;

EID: 33745417619     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.1080/00365520500442724     Document Type: Article

References (34)

1. Bosch J, Abraldes JG, Groszmann R. Current management of portai hypertension. J Hepatol 2003;38:S54-68.
2. Hadoke PWF, Hayes PC. In vitro evidence for vascular hyporesponsiveness in clinical and experimental cirrhosis. Pharmacol Ther 1997;75:51-68.
3. Martin P, Gines P, Schrier R. Nitric oxide as a mediator of hemodynamic abnormalities and sodium and water retention in cirrhosis. N Engl J Med 1998;339:533-41.
4. Wiest R, Groszmann RJ. The paradox of nitric oxide in cirrhosis and portal hypertension: too much, not enough. Hepatology 2002;35:478-91.
5. Vallance P, Moncada S. Hyperdynamic circulation in cirrhosis: a role for nitric oxide? Lancet 1991;337:776-8.
6. McNaughton L, Puttagunta L, Martinez-Cuesta MA, Kneteman N, Mayers I, Moqbel R, et al. Distribution of nitric oxide synthase in normal and cirrhotic human liver. Proc Natl Acad Sci USA 2002;99:17161-6.
7. Mohammed NA, El-Aleem SA, Appleton I, Maklouf MM, Said M, McMahon RF. Expression of nitric oxide synthase isoforms in human liver cirrhosis. J Pathol 2003;200:647-55.
8. Morales-Ruiz M, Jimenez W, Perez-Sala D, Ros J, Leivas A, Lamas S, et al. Increased nitric oxide synthase expression in arterial vessels of cirrhotic rats with ascites. Hepatology 1996;24:1481-6.
9. Sogni P, Smith APL, Gadano A, Lebrec D, Higenbottam TW. Induction of nitric oxide synthase II does not account for excess vascular nitric oxide production in experimental cirrhosis. J Hepatol 1997;26:1120-7.
10. Stumm MM, D'Orazio D, Sumanovski LT, Martin P-Y, Reichen J, Sieber CC. Endothelial, but not the inducible, nitric oxide synthase is detectable in normal and portal hypertensive rats. Liver 2002;22:441-50.
11. Tazi KA, Barriere E, Moreau R, Heller J, Sogni P, Pateron D, et al. Role of shear stress in aortic eNOS up-regulation in rats with biliary cirrhosis. Gastroenterology 2002;122:1869-77.
12. Fernandez-Varo G, Ros J, Morales-Ruiz M, Cejudo-Martin P, Arroyo V, Sole M, et al. Nitric oxide synthase 3-dependent vascular remodeling and circulatory dysfunction in cirrhosis. Am J Pathol 2003;162:1985-93.
13. Baylis C, Vallance P. Measurement of nitrite and nitrate levels in plasma and urine: what does this measure tell us about the activity of the endogenous nitric oxide system? Curr Opin Nephrol Hypertens 1998;7:59-62.
14. Rhodes P, Leone AM, Francis PL, Struthers AD, Moncada S, Rhodes PM. The L-arginine:nitric oxide pathway is the major source of plasma nitrite in fasted humans. Biochem Biophys Res Comm 1995;209:590-6.
15. Kelm M. Nitric oxide metabolism and breakdown. Biochim Biophys Acta 1999;1411:273-89.
16. Demoncheaux E, Higenbottam T, Kiely D, Wong J, Wharton S, Varcoe R, et al. Decreased whole body endogenous nitric oxide production in patients with primary pulmonary hypertension. J Vasc Res 2005;42:133-6.
17. Monaghan JM, Cook K, Gara D, Crowther D. Determination of nitrite and nitrate in human serum. J Chromatogr A 1997;770:143-9.
18. Armitage P, Berry G. Statistical methods in medical research, 3rd ed. London: Blackwell Science Ltd.; 1994.
19. Guarner C, Soriano G, Tomas A, Bulbena O, Novella MT, Balanzo J, et al. Increased serum nitrite and nitrate levels in patients with cirrhosis: relationship to endotoxemia. Hepatology 1993;18:1139-43.
20. Barak N, Zemel R, Ben-Ari Z, Braun M, Tur-Kaspa R. Nitric oxide metabolites in decompensated liver cirrhosis. Dig Dis Sci 1999;44:1338-41.
21. Lluch P, Torondel B, Medina P, Segarra G, Del Olmo JA, Serra MA, et al. Plasma concentrations of nitric oxide and asymmetric dimethylarginine in human alcoholic cirrhosis. J Hepatol 2004;41:55-9.
22. Crowther D, Monaghan JM, Cook K, Gara D. Nitrate and nitrite determination in complex matrices by gradient ion chromatography. Anal Commun 1996;33:51-2.
23. Weitzberg E, Lundberg JON. Nonenzymatic nitric oxide production in humans. Nitric Oxide 1998;2:1-7.
24. Guarner G, Soriano G, Tomas A, Bulbena O, Novella MT, Balanzo J, et al. Increased serum nitrite and nitrate levels in patients with cirrhosis: relationship to endotoxemia. Hepatology 1993;18:1139-43.
25. Campillo B, Bories PN, Benvenuti C, Dupeyron C. Serum and urinary nitrate levels in liver cirrhosis: endotoxemia, renal function and hyperdynamic circulation. J Hepatol 1996;25:707-14.
26. Castillo L, Beaumier L, Ajami AM, Young VR. Whole body nitric oxide synthesis in healthy men determined from [N-15]arginine-to-[N-15]citrulline labelling. Proc Natl Acad Sci USA 1996;93:11460-5.
27. Ottesen LH, Harry D, Frost M, Davies S, Khan K, Halliwell B, et al. Increased formation of S-nitrosothiols and nitrotyrosine in cirrhotic rats during endotoxemia. Free Radic Biol Med 2001;31:790-8.
28. Wu CT, Eiserich JP, Ansari AA, Coppel RL, Balasubramanian S, Bowlus CL, et al. Myeloperoxidase-positive inflammatory cells participate in bile duct damage in primary biliary cirrhosis through nitric oxide-mediated reactions. Hepatology 2003;38:1018-25.
29. Wennmalm A, Benthin G, Edlund A, Jungersten L, Kieler-Jensen N, Lundin S, et al. Metabolism and excretion of nitric oxide in humans. An experimental and clinical study. Circ Res 1993;73:1121-7.
30. Lauer T, Preik M, Rassaf T, Strauer BE, Deussen A, Feelisch M, et al. Plasma nitrite rather than nitrate reflects regional endothelial nitric oxide synthase activity but lacks intrinsic vasodilator action. Proc Natl Acad Sci USA 2001;98:12814-9.
31. Demoncheaux E, Higenbottam T, Foster P, Borland C, Smith A, Marriott H, et al. Circulating nitrite anions are a directly acting vasodilator and are donors for nitric oxide. Clin Sci (Lond) 2002;102:77-83.
32. Eiserich J, Baldus S, Brennan M, Ma W, Zhang C, Tousson A, et al. Myeloperoxidase, a leukocyte-derived vascular NO oxidase. Science 2002;296:2391-4.
33. Zhang R, Brennan ML, Shen Z, MacPherson JC, Schmitt D, Molenda CE, et al. Myeloperoxidase functions as a major enzymatic catalyst for initiation of lipid peroxidation at sites of inflammation. J Biol Chem 2002;277:46116-22.
34. Cosby K, Partovi KS, Crawford JH, Patel RP, Reiter CD, Martyr S, et al. Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation. Nat Med 2003;9:1498-505.